文献速递静脉血栓栓塞

Caprini评分用于静脉血栓栓塞症风险评估:应用、验证与未来方向的范围综述

The Caprini score for venous thromboembolism risk assessment: A scoping review of applications, validation, and future directions.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-20

该范围综述检索2021至2025年文献,纳入275项关于Caprini静脉血栓栓塞症风险评估模型在成人患者中验证、应用或改良的研究。分析显示支持、中立和批判立场分别占41.1%、34.9%和24.0%;

要点

  • Caprini评分在部分情境下有效,但特定人群准确性不足且操作复杂。
  • 改良或新模型的配对AUC平均提升0.130,98.1%的比较显示改善。
  • 改良方向包括生物标志物整合、专科简化模型、人工智能和流程优化。

核心结论

  • Caprini评分的学术讨论呈现碎片化,既有验证的实用性也有公认局限,推动大量模型改良。
  • 改良模型在原始评分表现欠佳的专科中报告了显著性能提升,VTE风险评估趋向更精准和情境适配。

研究设计与样本

  • 遵循PRISMA-ScR框架的范围综述,系统检索PubMed、Web of Science、Embase和Cochrane Library。
  • 从754条记录中纳入275项研究,提取研究特征、预测性能指标(如AUC)、作者结论和模型改良细节。

主要发现

  • 275项研究中,支持立场113项(41.1%),中立96项(34.9%),批判66项(24.0%)。
  • 平均AUC提升为0.130(SD 0.117),中位提升0.105(IQR 0.106),98.1%的比较显示改善。
  • 批判观点常提及特定人群(如内科住院患者)准确性差和操作复杂性。
  • 111项研究提出改良,分为生物标志物整合(33项)、专科/简化模型开发(45项)、人工智能/机器学习应用(23项)和评估流程优化(30项)。

临床怎么用

  • 临床使用Caprini评分时应认识其在特定人群中的准确性局限和操作复杂性。
  • 在原始评分表现欠佳的专科中,可关注或采用经改良的专科特异性模型以提高风险评估准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to characterize the contemporary academic landscape surrounding the Caprini venous thromboembolism (VTE) risk assessment model (RAM), including its application patterns, reported performance, evolving scholarly perspectives, and dominant refinement strategies. METHODS: A scoping review was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews framework. PubMed, Web of Science, Embase, and the Cochrane Library were systematically searched for studies published between January 1, 2021, and December 31, 2025, using terms including "Caprini score," "venous thromboembolism," and "risk assessment." Eligible studies reported on the validation, application, or modification of the Caprini RAM in adult patients. Data on study characteristics, predictive performance metrics (eg, area under the curve [AUC]), author conclusions, and model refinement details were extracted. RESULTS: From 754 identified records, 275 studies met the inclusion criteria. Analysis of 275 studies with codable author perspectives revealed a distribution of supportive (113 studies; 41.1%), neutral (96 studies; 34.9%), and critical (66 studies; 24.0%) stances. Fifty-two studies providing paired AUC data reported a mean baseline Caprini score AUC of 0.702 (standard deviation [SD], 0.104), compared with a mean AUC of 0.832 (SD, 0.080) for refined or new models. The mean AUC improvement was 0.130 (SD, 0.117), with a median improvement of 0.105 (interquartile range, 0.106); improvements were observed in 98.1% of these comparisons. Critical perspectives frequently cited poor accuracy in specific populations (eg, medical inpatients) and operational complexity. In response, 111 studies proposed refinements categorized into four domains: integration of biomarkers (33 studies), development of specialty-specific/simplified models (45 studies), application of artificial intelligence/machine learning (23 studies), and optimization of assessment processes (30 studies). CONCLUSIONS: This review quantifies a fragmented scholarly discourse on the Caprini RAM, reflecting its validated utility in certain contexts alongside recognized limitations driving extensive model refinement. The significant performance gains reported for refined models, particularly in specialties where the original score underperforms, highlight the ongoing evolution of VTE risk assessment toward more precise and context-adapted tools.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhang J, Jiang Y, Zhou D, et al. The Caprini score for venous thromboembolism risk assessment: A scoping review of applications, validation, and future directions. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41864535. doi:10.1016/j.jvsv.2026.102483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。